Establishment and Characterization of Primary Human Ovarian Cancer Stem Cell Line (CD44+ve). Journal of Cancer Research Updates, [S. l.], v. 5, n. 2, p.  59–66, 2016. DOI: 10.6000/1929-2279.2016.05.02.3. Disponível em: https://neoplasiaresearch.com/index.php/jcru/article/view/464. Acesso em: 16 apr. 2026.